secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2024-07-22T23:59:59+00:00
Accession:  0001013762-24-000518
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma raises $2.1M in registered direct offering of 763,638 shares at $2.75
--------------------------------------------------------------------------------

- Gross proceeds ~$2.1M from sale of 763,638 common shares at $2.75 each.
- Concurrent private placement of warrants to buy 763,638 shares at $2.75, exercisable for 5 years.
- H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash and 57,273 placement agent warrants.
- Net proceeds to be used for working capital and general corporate purposes.
- Offering closed on July 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000101376224000518/0001013762-24-000518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000101376224000518/ea0209765-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001013762-24-000518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer